Insider Trading activities of Gilead Sciences Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gilead Sciences Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gilead Sciences Inc since year 2005. Table 2 shows the detailed insider transactions of Gilead Sciences Inc since 2005. The reporting company's ticker symbol is GILD. The reporting company's CIK number is 882095.
The total value of stock buying since 2005 is $2,912,783.
The total value of stock sales since 2005 is $2,341,165,981.
The total value of stock option exercises since 2005 is $444,271,390.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Gilead Sciences Inc (GILD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 98,333 $8,096,292 90,583 $2,011,770
2017-09 0 $0 150,153 $12,589,750 124,333 $2,831,726
2017-08 0 $0 198,333 $15,650,553 188,152 $4,193,911
2017-07 0 $0 118,333 $8,522,157 107,833 $2,513,314
2017-06 0 $0 78,333 $5,109,653 73,333 $1,582,159
2017-05 0 $0 88,276 $6,019,646 97,268 $1,755,954
2017-04 0 $0 73,333 $4,946,750 73,333 $1,582,159
2017-03 0 $0 78,333 $5,498,566 73,506 $1,582,159
2017-02 0 $0 93,698 $6,733,444 208,211 $4,430,170
2017-01 0 $0 73,337 $5,385,649 73,337 $1,582,245
2016-12 0 $0 0 $0 6,441 $0
2016-11 0 $0 215,000 $16,044,490 205,000 $3,813,525
2016-10 0 $0 100,000 $7,809,500 100,000 $1,639,500
2016-09 0 $0 175,000 $13,633,499 170,000 $3,091,300
2016-08 0 $0 175,500 $13,453,608 172,000 $3,156,765
2016-07 0 $0 214,000 $18,079,938 216,500 $3,525,550
2016-06 0 $0 214,000 $18,580,632 214,000 $3,525,550
2016-05 0 $0 269,092 $23,564,059 274,956 $6,480,206
2016-04 0 $0 259,000 $24,505,556 249,874 $4,493,789
2016-03 0 $0 219,000 $19,291,140 214,169 $3,525,550
2016-02 0 $0 108,250 $9,101,340 102,000 $1,704,965
2016-01 0 $0 102,000 $10,044,000 102,000 $1,691,394
2015-12 0 $0 334,000 $34,907,899 334,104 $5,422,080
2015-11 0 $0 363,796 $39,121,995 353,000 $5,909,675
2015-10 0 $0 370,500 $36,903,151 368,500 $6,376,820
2015-09 0 $0 358,250 $37,639,158 350,000 $5,950,050
2015-08 0 $0 511,213 $58,175,503 435,000 $7,665,159
2015-07 0 $0 340,000 $39,685,815 340,500 $5,573,295
2015-06 0 $0 377,000 $43,440,162 375,000 $6,335,516
2015-05 0 $0 381,842 $40,105,886 419,890 $7,134,186
2015-04 0 $0 234,000 $23,189,716 232,000 $3,979,400
2015-03 0 $0 239,000 $24,551,369 237,167 $3,962,310
2015-02 10,000 $999,150 272,192 $28,635,848 270,192 $4,703,861
2015-01 0 $0 239,000 $23,077,341 237,000 $3,723,235
2014-12 0 $0 353,456 $36,264,861 353,542 $3,634,718
2014-11 0 $0 386,712 $42,231,574 395,512 $4,546,743
2014-10 0 $0 344,520 $36,320,981 342,520 $3,550,262
2014-09 0 $0 332,520 $35,716,100 330,520 $3,325,762
2014-08 0 $0 278,813 $25,944,306 275,009 $4,776,223
2014-07 0 $0 245,353 $21,104,563 243,353 $3,715,524
2014-06 0 $0 307,179 $24,957,200 288,353 $3,990,981
2014-05 0 $0 335,953 $26,730,357 461,857 $5,821,383
2014-04 0 $0 270,353 $19,205,075 268,353 $3,451,424
2014-03 0 $0 294,353 $23,484,271 292,520 $3,831,716
2014-02 0 $0 454,989 $37,265,872 452,021 $7,635,939
2014-01 0 $0 599,225 $46,150,513 597,225 $9,485,359
2013-12 0 $0 477,242 $35,285,781 475,328 $5,185,458
2013-11 0 $0 1,676,793 $117,078,733 1,691,734 $14,445,166
2013-10 0 $0 477,242 $30,400,118 473,242 $5,150,487
2013-09 0 $0 537,842 $33,368,325 533,842 $5,929,249
2013-08 0 $0 570,962 $34,859,735 566,962 $7,132,511
2013-07 0 $0 713,842 $40,184,959 709,842 $8,616,229
2013-06 0 $0 422,242 $22,375,790 418,242 $3,789,853
2013-05 0 $0 312,242 $15,667,047 355,058 $2,580,623
2013-04 0 $0 326,210 $15,750,625 321,242 $2,918,467
2013-03 0 $0 416,346 $18,243,013 408,209 $5,124,082
2013-02 10,000 $430,490 0 $0 0 $0
2013-01 0 $0 267,671 $19,557,873 265,671 $5,761,818
2012-12 0 $0 167,500 $12,575,341 182,425 $2,110,370
2012-11 0 $0 1,020,346 $73,805,845 1,057,521 $30,014,871
2012-10 0 $0 283,400 $19,340,389 273,580 $4,431,492
2012-09 0 $0 468,200 $27,663,500 467,200 $11,724,677
2012-08 0 $0 280,416 $15,509,625 527,950 $9,240,406
2012-07 0 $0 238,669 $12,533,189 242,169 $3,313,747
2012-06 0 $0 153,450 $7,496,577 152,450 $1,436,279
2012-05 0 $0 157,450 $8,143,038 198,757 $1,513,719
2012-04 0 $0 227,781 $11,473,584 227,781 $2,883,879
2012-03 0 $0 198,448 $9,221,513 187,533 $2,573,023
2012-02 10,000 $439,960 277,450 $15,229,141 263,550 $4,486,460
2012-01 0 $0 18,000 $809,100 24,780 $629,348
2011-12 0 $0 100,320 $4,011,804 105,820 $934,678
2011-11 0 $0 100,320 $4,117,839 209,320 $1,846,465
2011-10 0 $0 115,320 $4,631,219 114,320 $1,185,673
2011-09 0 $0 105,320 $4,219,429 104,320 $1,018,858
2011-07 0 $0 120,320 $5,031,706 121,320 $1,252,298
2011-06 0 $0 105,820 $4,388,487 104,820 $1,026,278
2011-05 0 $0 100,320 $4,017,025 142,384 $870,848
2011-04 0 $0 105,320 $4,475,222 104,320 $950,898
2011-03 0 $0 324,960 $13,089,551 323,960 $3,134,898
2011-02 0 $0 8,000 $308,724 7,000 $106,854
2011-01 0 $0 9,500 $356,908 9,390 $129,752
2010-12 0 $0 26,500 $980,542 32,852 $472,657
2010-11 0 $0 118,000 $4,530,998 118,000 $1,660,755
2010-10 0 $0 28,006 $1,081,720 147,984 $628,353
2010-08 0 $0 0 $0 293,519 $1,485,564
2010-07 0 $0 100,000 $3,515,000 100,000 $369,900
2010-06 0 $0 100,000 $3,382,500 110,000 $610,450
2010-05 12,800 $494,016 105,000 $4,175,900 110,000 $504,175
2010-04 0 $0 105,000 $4,860,865 117,089 $651,311
2010-03 0 $0 105,500 $5,005,802 105,500 $453,857
2010-02 0 $0 267,754 $12,690,647 229,000 $2,945,169
2010-01 0 $0 105,500 $4,720,165 105,500 $454,057
2009-12 0 $0 243,000 $11,179,010 260,748 $2,352,252
2009-11 0 $0 172,920 $8,082,043 152,584 $1,046,929
2009-10 0 $0 153,000 $6,889,370 148,000 $1,011,288
2009-09 0 $0 183,000 $8,441,750 178,000 $999,168
2009-08 0 $0 312,217 $14,338,019 340,400 $1,647,977
2009-07 2,500 $120,700 417,948 $19,836,921 386,000 $5,061,923
2009-06 0 $0 183,000 $8,076,640 178,000 $970,323
2009-05 0 $0 641,640 $28,241,896 686,640 $5,824,429
2009-04 0 $0 332,876 $15,435,044 341,376 $2,512,985
2009-03 0 $0 180,000 $7,960,245 178,000 $970,161
2009-02 0 $0 298,652 $15,474,361 302,500 $3,328,601
2009-01 0 $0 238,500 $11,870,550 247,000 $1,989,115
2008-12 0 $0 68,000 $2,984,011 115,024 $760,397
2008-11 0 $0 269,950 $12,134,759 169,950 $2,393,414
2008-10 0 $0 165,450 $7,533,074 283,586 $2,426,402
2008-09 0 $0 80,450 $4,089,020 80,450 $601,215
2008-08 0 $0 90,450 $5,118,203 90,450 $363,495
2008-07 0 $0 403,950 $20,994,537 541,950 $4,481,850
2008-06 0 $0 150,450 $8,170,693 150,450 $867,495
2008-05 0 $0 336,266 $18,058,567 142,442 $1,554,363
2008-04 0 $0 553,950 $28,854,272 397,950 $3,805,148
2008-03 0 $0 201,450 $9,657,245 208,450 $1,372,511
2008-02 0 $0 232,670 $10,336,805 237,950 $2,730,930
2008-01 0 $0 365,600 $16,738,441 339,500 $2,146,608
2007-12 0 $0 130,000 $6,016,530 190,892 $1,050,120
2007-11 0 $0 192,700 $8,499,104 163,000 $701,070
2007-10 10,000 $418,400 351,500 $15,677,105 310,000 $2,495,289
2007-09 0 $0 143,000 $5,350,211 367,000 $1,071,040
2007-08 0 $0 90,125 $3,409,873 80,000 $342,640
2007-07 0 $0 122,500 $4,846,441 122,500 $714,430
2007-06 0 $0 95,850 $7,785,981 69,750 $472,440
2007-05 0 $0 465,918 $38,761,923 485,250 $10,948,612
2007-04 121 $10,067 239,999 $19,688,159 178,944 $1,778,357
2007-03 0 $0 147,205 $10,563,165 116,550 $888,903
2007-02 0 $0 376,570 $26,966,657 339,650 $4,623,669
2007-01 0 $0 45,050 $2,934,519 45,050 $179,428
2006-12 0 $0 39,750 $2,604,321 47,810 $223,002
2006-11 0 $0 173,783 $11,873,250 172,878 $1,645,937
2006-10 0 $0 420,750 $28,630,831 419,750 $4,033,886
2006-09 0 $0 47,450 $2,998,440 42,612 $146,266
2006-08 0 $0 511,693 $31,507,622 517,896 $4,745,504
2006-07 0 $0 73,500 $4,484,111 66,500 $605,756
2006-06 0 $0 0 $0 2,788 $31,883
2006-05 0 $0 256,500 $14,511,608 326,404 $2,429,080
2006-04 0 $0 0 $0 10,000 $32,650
2006-03 0 $0 36,500 $2,177,236 61,394 $329,482
2006-02 0 $0 526,960 $31,818,501 469,518 $4,590,988
2005-12 0 $0 0 $0 9,300 $70,735
2005-11 0 $0 26,000 $1,407,360 0 $0
2005-08 0 $0 10,000 $421,100 0 $0
2005-05 0 $0 256,318 $10,101,825 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Gilead Sciences Inc insiders (GILD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-02 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Sale 25,000 82.68 2,067,000
2017-10-02 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Option Ex 17,250 24.91 429,611
2017-10-02 Martin John C (Executive Chairman) Sale 73,333 82.22 6,029,292
2017-10-02 Martin John C (Executive Chairman) Option Ex 73,333 21.57 1,582,159
2017-09-07 Washington Robin L (EVP, CFO) Sale 51,820 85.00 4,404,700
2017-09-07 Washington Robin L (EVP, CFO) Option Ex 33,750 24.30 819,956
2017-09-01 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Sale 25,000 83.25 2,081,325
2017-09-01 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Option Ex 17,250 24.91 429,611
2017-09-01 Martin John C (Executive Chairman) Sale 73,333 83.23 6,103,725
2017-09-01 Martin John C (Executive Chairman) Option Ex 73,333 21.57 1,582,159
2017-08-31 Meyers James R (EVP Worldwide Commercial Ops) Sale 60,000 83.33 4,999,620
2017-08-31 Meyers James R (EVP Worldwide Commercial Ops) Option Ex 60,000 21.00 1,260,000
2017-08-30 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Sale 50,000 79.00 3,950,000
2017-08-30 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Option Ex 43,125 25.95 1,118,964
2017-08-19 Kramer Kelly A. (Director) Option Ex 1,339 .00 0
2017-08-10 Meyers James R (EVP Worldwide Commercial Ops) Option Ex 820 .00 0
2017-08-10 Young Kevin (Chief Operating Officer) Option Ex 910 .00 0
2017-08-01 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Sale 15,000 75.88 1,138,185
2017-08-01 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Option Ex 8,625 26.99 232,788
2017-08-01 Martin John C (Executive Chairman) Sale 73,333 75.86 5,562,748
2017-08-01 Martin John C (Executive Chairman) Option Ex 73,333 21.57 1,582,159
2017-07-21 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Sale 40,000 74.00 2,960,000
2017-07-21 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Option Ex 34,500 26.99 931,155
2017-07-03 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Sale 5,000 71.06 355,295
2017-07-03 Martin John C (Executive Chairman) Sale 73,333 71.00 5,206,862
2017-07-03 Martin John C (Executive Chairman) Option Ex 73,333 21.57 1,582,159
2017-06-01 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Sale 5,000 65.02 325,115
2017-06-01 Martin John C (Executive Chairman) Sale 73,333 65.24 4,784,538
2017-06-01 Martin John C (Executive Chairman) Option Ex 73,333 21.57 1,582,159
2017-05-09 Lofton Kevin E (Director) Option Ex 1,787 .00 0
2017-05-09 Cogan John Francis (Director) Sale 9,943 67.25 668,666
2017-05-09 Cogan John Francis (Director) Option Ex 16,787 10.35 173,795
2017-05-09 Wilson Gayle E (Director) Option Ex 1,787 .00 0
2017-05-09 Wold Olsen Per (Director) Option Ex 1,787 .00 0
2017-05-09 Madigan John W (Director) Option Ex 1,787 .00 0
2017-05-01 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Sale 5,000 68.31 341,530
2017-05-01 Martin John C (Executive Chairman) Sale 73,333 68.31 5,009,450
2017-05-01 Martin John C (Executive Chairman) Option Ex 73,333 21.57 1,582,159
2017-04-03 Martin John C (Executive Chairman) Sale 73,333 67.46 4,946,750
2017-04-03 Martin John C (Executive Chairman) Option Ex 73,333 21.57 1,582,159
2017-03-30 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Sale 5,000 67.48 337,390
2017-03-01 Moore Nicholas G (Director) Option Ex 173 .00 0
2017-03-01 Martin John C (Executive Chairman) Sale 73,333 70.38 5,161,176
2017-03-01 Martin John C (Executive Chairman) Option Ex 73,333 21.57 1,582,159
2017-02-23 Wilson Gayle E (Director) Sale 20,365 69.30 1,411,375
2017-02-23 Wilson Gayle E (Director) Option Ex 33,350 20.70 690,511
2017-02-23 Milligan John F (President and CEO) Option Ex 100,000 21.57 2,157,500
2017-02-10 Young Kevin (Chief Operating Officer) Option Ex 908 .00 0
2017-02-01 Young Kevin (Chief Operating Officer) Option Ex 620 .00 0
2017-02-01 Martin John C (Executive Chairman) Sale 73,333 72.57 5,322,069
2017-02-01 Martin John C (Executive Chairman) Option Ex 73,333 21.57 1,582,159
2017-01-03 Martin John C (Executive Chairman) Sale 73,337 73.44 5,385,649
2017-01-03 Martin John C (Executive Chairman) Option Ex 73,337 21.57 1,582,245
2016-12-01 Wilson Gayle E (Director) Option Ex 4,294 .00 0
2016-11-18 Madigan John W (Director) Sale 105,000 74.86 7,860,090
2016-11-18 Madigan John W (Director) Option Ex 105,000 20.70 2,174,025
2016-11-09 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Sale 10,000 79.00 790,000
2016-11-01 Martin John C (Executive Chairman) Sale 100,000 73.94 7,394,400
2016-11-01 Martin John C (Executive Chairman) Option Ex 100,000 16.39 1,639,500
2016-10-03 Martin John C (Executive Chairman) Sale 100,000 78.09 7,809,500
2016-10-03 Martin John C (Executive Chairman) Option Ex 100,000 16.39 1,639,500
2016-09-22 Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) Sale 5,000 81.84 409,219
2016-09-06 Milligan John F (President and CEO) Sale 70,000 77.74 5,442,080
2016-09-06 Milligan John F (President and CEO) Option Ex 70,000 20.74 1,451,800
2016-09-01 Martin John C (Executive Chairman) Sale 100,000 77.82 7,782,200
2016-09-01 Martin John C (Executive Chairman) Option Ex 100,000 16.39 1,639,500
2016-08-24 Lofton Kevin E (Director) Sale 3,500 81.97 286,898
2016-08-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 79.81 159,620
2016-08-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 32.73 65,465
2016-08-01 Milligan John F (President and CEO) Sale 70,000 70.94 4,965,590
2016-08-01 Milligan John F (President and CEO) Option Ex 70,000 20.74 1,451,800
2016-08-01 Martin John C (Executive Chairman) Sale 100,000 80.42 8,041,500
2016-08-01 Martin John C (Executive Chairman) Option Ex 100,000 16.39 1,639,500
2016-07-31 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,500 .00 0
2016-07-05 Milligan John F (President and CEO) Sale 112,000 84.62 9,477,888
2016-07-05 Milligan John F (President and CEO) Option Ex 112,000 16.39 1,836,240
2016-07-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 83.12 166,250
2016-07-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 24.91 49,810
2016-07-01 Martin John C (Executive Chairman) Sale 100,000 84.36 8,435,800
2016-07-01 Martin John C (Executive Chairman) Option Ex 100,000 16.39 1,639,500
2016-06-06 Milligan John F (President and CEO) Sale 112,000 86.92 9,734,592
2016-06-06 Milligan John F (President and CEO) Option Ex 112,000 16.39 1,836,240
2016-06-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 87.02 174,040
2016-06-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 24.91 49,810
2016-06-01 Martin John C (Executive Chairman) Sale 100,000 86.72 8,672,000
2016-06-01 Martin John C (Executive Chairman) Option Ex 100,000 16.39 1,639,500
2016-05-31 Carter Paul Rutherford (EVP Commercial Ops) Sale 57,092 86.85 4,958,611
2016-05-31 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 57,092 52.62 3,004,466
2016-05-06 Whitley Richard James (Director) Option Ex 1,466 .00 0
2016-05-06 Davignon Etienne (Director) Option Ex 1,466 .00 0
2016-05-06 Wold Olsen Per (Director) Option Ex 1,466 .00 0
2016-05-06 Madigan John W (Director) Option Ex 1,466 .00 0
2016-05-02 Milligan John F (President and CEO) Sale 112,000 87.70 9,822,848
2016-05-02 Milligan John F (President and CEO) Option Ex 112,000 16.39 1,836,240
2016-05-02 Martin John C (Executive Chairman) Sale 100,000 87.83 8,782,600
2016-05-02 Martin John C (Executive Chairman) Option Ex 100,000 16.39 1,639,500
2016-04-19 Alton Gregg H (EVP, Corp & Med Affairs) Sale 40,000 100.01 4,000,320
2016-04-19 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 35,874 26.99 968,239
2016-04-04 Milligan John F (President and CEO) Sale 112,000 94.71 10,607,296
2016-04-04 Milligan John F (President and CEO) Option Ex 112,000 16.39 1,836,240
2016-04-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 91.34 182,680
2016-04-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 24.91 49,810
2016-04-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,000 91.23 456,160
2016-04-01 Martin John C (Executive Chairman) Sale 100,000 92.59 9,259,100
2016-04-01 Martin John C (Executive Chairman) Option Ex 100,000 16.39 1,639,500
2016-03-14 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,000 90.00 450,000
2016-03-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 87.90 175,800
2016-03-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 24.91 49,810
2016-03-01 Moore Nicholas G (Director) Option Ex 169 .00 0
2016-03-01 Milligan John F (President, COO and Director) Sale 112,000 87.80 9,833,040
2016-03-01 Milligan John F (President, COO and Director) Option Ex 112,000 16.39 1,836,240
2016-03-01 Martin John C (Chairman and CEO) Sale 100,000 88.32 8,832,300
2016-03-01 Martin John C (Chairman and CEO) Option Ex 100,000 16.39 1,639,500
2016-02-16 Washington Robin L (EVP, CFO) Sale 6,250 90.72 567,000
2016-02-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 82.32 164,640
2016-02-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 32.73 65,465
2016-02-01 Martin John C (Chairman and CEO) Sale 100,000 83.70 8,369,700
2016-02-01 Martin John C (Chairman and CEO) Option Ex 100,000 16.39 1,639,500
2016-01-04 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 99.20 198,400
2016-01-04 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 25.95 51,894
2016-01-04 Martin John C (Chairman and CEO) Sale 100,000 98.46 9,845,600
2016-01-04 Martin John C (Chairman and CEO) Option Ex 100,000 16.39 1,639,500
2015-12-15 Bischofberger Norbert W (EVP, R&D and CSO) Sale 70,000 102.44 7,170,729
2015-12-15 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 21.42 1,499,400
2015-12-07 Milligan John F (President and COO) Sale 100,000 103.25 10,324,600
2015-12-07 Milligan John F (President and COO) Option Ex 100,000 14.50 1,450,300
2015-12-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 106.38 212,760
2015-12-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 26.99 53,980
2015-12-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 12,000 106.36 1,276,260
2015-12-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 10,000 24.30 242,950
2015-12-01 Wilson Gayle E Option Ex 2,104 .00 0
2015-12-01 Martin John C (Chairman and CEO) Sale 150,000 106.16 15,923,550
2015-12-01 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450
2015-11-24 Whitley Richard James Sale 169 106.48 17,994
2015-11-24 Cogan John Francis Sale 15,000 105.95 1,589,190
2015-11-24 Cogan John Francis Option Ex 15,000 20.70 310,575
2015-11-23 Whitley Richard James Sale 2,863 107.18 306,844
2015-11-20 Whitley Richard James Sale 5,514 106.98 589,915
2015-11-16 Bischofberger Norbert W (EVP, R&D and CSO) Sale 70,000 103.10 7,217,000
2015-11-16 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 23.75 1,662,850
2015-11-09 Milligan John F (President and COO) Sale 100,000 107.94 10,793,500
2015-11-09 Milligan John F (President and COO) Option Ex 100,000 14.50 1,450,300
2015-11-05 Washington Robin L (EVP, CFO) Option Ex 6,000 .00 0
2015-11-02 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 108.36 216,712
2015-11-02 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 33.77 67,550
2015-11-02 Alton Gregg H (EVP, Corp & Med Affairs) Sale 12,000 109.38 1,312,584
2015-11-02 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 10,000 24.30 242,950
2015-11-02 Washington Robin L (EVP, CFO) Sale 6,250 109.37 683,556
2015-11-02 Martin John C (Chairman and CEO) Sale 150,000 109.30 16,394,700
2015-11-02 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450

Insider trading activities including stock purchases, stock sales, and option exercises of GILD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gilead Sciences Inc (symbol GILD, CIK number 882095) see the Securities and Exchange Commission (SEC) website.